These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33250272)

  • 1. The Potential of
    Wang X; McFarland A; Madsen JJ; Aalo E; Ye L
    Trends Pharmacol Sci; 2021 Jan; 42(1):19-30. PubMed ID: 33250272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased agonism: An emerging paradigm in GPCR drug discovery.
    Rankovic Z; Brust TF; Bohn LM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):241-250. PubMed ID: 26707396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biasing GPCR signaling from inside.
    Shukla AK
    Sci Signal; 2014 Jan; 7(310):pe3. PubMed ID: 24473194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for the discovery of biased GPCR ligands.
    Bermudez M; Nguyen TN; Omieczynski C; Wolber G
    Drug Discov Today; 2019 Apr; 24(4):1031-1037. PubMed ID: 30831262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPCR Allosteric Modulator Discovery.
    Wu Y; Tong J; Ding K; Zhou Q; Zhao S
    Adv Exp Med Biol; 2019; 1163():225-251. PubMed ID: 31707706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
    Tan L; Yan W; McCorvy JD; Cheng J
    J Med Chem; 2018 Nov; 61(22):9841-9878. PubMed ID: 29939744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
    DeWire SM; Violin JD
    Circ Res; 2011 Jul; 109(2):205-16. PubMed ID: 21737816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and Opportunities in Drug Discovery of Biased Ligands.
    Rodríguez-Espigares I; Kaczor AA; Stepniewski TM; Selent J
    Methods Mol Biol; 2018; 1705():321-334. PubMed ID: 29188569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology combination to address GPCR allosteric modulator drug-discovery pitfalls.
    Schann S; Bouvier M; Neuville P
    Drug Discov Today Technol; 2013; 10(2):e261-7. PubMed ID: 24050277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
    Xiao K; Sun J
    Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ye L; Wang X; McFarland A; Madsen JJ
    Structure; 2022 Oct; 30(10):1372-1384. PubMed ID: 36130592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs).
    Lee Y; Lazim R; Macalino SJY; Choi S
    Curr Opin Struct Biol; 2019 Apr; 55():147-153. PubMed ID: 31102980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting in silico GPCR conformations with ultra-large library screening for hit discovery.
    Sala D; Batebi H; Ledwitch K; Hildebrand PW; Meiler J
    Trends Pharmacol Sci; 2023 Mar; 44(3):150-161. PubMed ID: 36669974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPCR structure and function relationship: identification of a biased apelin receptor mutant.
    Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA
    Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.